Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will…
Bayer continues to enhance its comprehensive radiology portfolio by advancing innovations in Artificial Intelligence (AI) and expanding its product pipeline. These advancements will be showcased at the 2024 Radiological Society…
Sickday Medical House Calls, the largest and longest-serving medical house call practice in New York City, is reshaping the way travelers experience healthcare. For nearly two decades, Sickday has been…
Teladoc Health has introduced a groundbreaking technology that combines artificial intelligence (AI) and real-time monitoring to enhance patient safety in hospitals. This innovative solution, known as Virtual Sitter, is designed…
Galderma recently announced that the full results from the Phase III OLYMPIA 1 trial, which evaluated the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis, were published…
Oxford Nanopore Technologies, a leader in advanced nanopore-based molecular sensing technology, has announced a groundbreaking collaboration with UK Biobank to create the world’s first large-scale, comprehensive epigenetic dataset. Utilizing Oxford…
The Menarini Group, a global leader in pharmaceuticals and diagnostics, along with its subsidiary Stemline Therapeutics, will present new and expanded data on ORSERDU® (elacestrant) at the 2024 San Antonio…
HCA Healthcare, Inc. (NYSE:HCA), one of the largest healthcare providers in the United States, proudly announced the success of its sixth annual “Crush the Crisis” national prescription drug take-back day,…
The BioFuture™ 2024 conference, organized by Demy-Colton, concluded in New York and virtually, marking the largest turnout in the event’s history. This year’s conference brought together more than 100 speakers,…
Rigaku Corporation, a global leader in X-ray analytical equipment and a member of the Rigaku Holdings Group, has officially opened the Rigaku Bioscience Laboratory in Cambridge, Massachusetts. Rigaku Corporation has…
Laekna, Inc. (2105.HK), a global biotech company focused on developing novel therapies for metabolic and cancer diseases, is excited to announce a clinical collaboration with Eli Lilly and Company (Lilly),…
Pharmanovia, a global pharmaceutical company focused on commercializing innovative medicines and revitalizing established ones, today announced the expansion of its oncology portfolio with a new licensing agreement for catumaxomab. This…